Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Current recommendations and uncertainties for surgical treatment of infective endocarditis: a comparison of American and European cardiovascular guidelines

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Heart transplantation: focus on donor recovery strategies, left ventricular assist devices, and novel therapies

    Research output: Contribution to journalReviewResearchpeer-review

  2. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Volunteer first responders for out-of-hospital cardiac arrest at home: the missing link for improved survival?

    Research output: Contribution to journalEditorialResearchpeer-review

  4. Risk of sports-related sudden cardiac death in women

    Research output: Contribution to journalReviewResearchpeer-review

  5. 2021 ESC/EACTS Guidelines for the management of valvular heart disease

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Surgery is an effective therapy in the treatment of left-sided infective endocarditis (IE) in patients for whom antibiotic treatment alone is unlikely to be curative or may be associated with ongoing risk of complications. However, the interplay between indication for surgery, its risk, and timing is complex and there continue to be challenges in defining the effects of surgery on disease-related outcome. Guidelines published by the American College of Cardiology/American Heart Association and the European Society of Cardiology provide recommendations for the use of surgery in IE, but these are limited by a low level of evidence related to predominantly observational studies with inherent selection and survival biases. Evidence to guide the timing of surgery in IE is less robust, and predominantly based on expert consensus. Delays between IE diagnosis and recognition of an IE complication as a surgical indication and transfers to surgical centres also impact surgical timing. This comparison of the two guidelines exposes areas of uncertainty and gaps in current evidence for the use of surgery in IE across different indications, particularly related to its timing and consideration of operative risk.

Original languageEnglish
JournalEuropean Heart Journal
Volume43
Issue number17
Pages (from-to)1617-1625
Number of pages9
ISSN0195-668X
DOIs
Publication statusPublished - 1 May 2022

Bibliographical note

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

    Research areas

  • American Heart Association, Anti-Bacterial Agents/therapeutic use, Endocarditis, Bacterial, Endocarditis/drug therapy, Humans, Uncertainty, United States/epidemiology, Heart, Surgery, Endocarditis, Guideline, Valve

ID: 71203079